MED: Dermatology Flashcards

1
Q

Management of acne vulgaris?

A

1. Topical combination therapy 12w:

  • topical adapalene + benzoyl peroxide
  • topical tretinoin + clindamycin
  • topical benzoyl peroxide + clindamycin

2a. Oral abx (max 3m) + topical BPO /+ adapalene:

  • 1st line = tetracyclines (lymecycline, doxycycline)
  • 2nd line = macrolides (erythromycin)

2b. COCP + BPO/adapalene

  • E.g. Dianette (co-cyprindiol)

3. Dermatologist referral & oral isotretinoin

  • Must be on 2 forms of contraception
  • SE > dryness, pruritis, conjunctivitis, muscle aches, deranged LFTs
  • Associated with low mood and suicidal ideation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What may precipitate guttate psoriasis?

A

Streptococcal infection 2-4 weeks prior to the lesions appearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical features of guttate psoriasis?

A
  • Tear drop papules on the trunk and limbs
  • Pink, scaly patches or plaques of psoriasis
  • Tends to be acute onset over days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of guttate psoriasis?

A

> > Most cases resolve spontaneously within 2-3 months

  • Topical agents as per psoriasis
  • UVB phototherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is actinic keratoses?

A

Represent dysplastic epidermal lesions, often considered precursors to cutaneous squamous cell carcinoma (cSCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical features of actinic keratoses?

A
  • small, crusty or scaly patches / pustules / lesions
  • may be pink, red, brown or the same colour as the skin
  • typically on sun-exposed areas e.g. temples of head
  • multiple lesions may be present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Main concern with actinic keratoses?

A

While some AKs may regress spontaneously, a subset can progress to invasive SCC, necessitating prompt intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Histological findings in actinic keratoses?

A

Atypical keratinocytes confined to the lower third of the epidermis (corresponding to in-situ SCC when full-thickness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of actinic keratoses?

A
  • Prevention of further risk - sun avoidance, sun cream
  • Fluorouracil cream - typically 2-3 week course, skin will become red/inflamed - sometimes topical hydrocortisone given to help settle inflammation
  • Topical diclofenac - may be used for mild AKs, moderate efficacy but fewer side-effects
  • Topical imiquimod - good efficacy
  • Cryotherapy
  • Curettage and cautery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical features of BCC?

A
  • Lesions are also known as rodent ulcers and are characterised by slow-growth and local invasion
  • Sun-exposed sites - esp head and neck
  • Initially a pearly, flesh-coloured papule with telangiectasia
  • May later ulcerate leaving a central ‘crater’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management of BCC?

A

Referral:

  • If BCC is suspected, a routine referral should be made

Management options:

  • surgical removal
  • curettage
  • cryotherapy
  • topical cream: imiquimod, fluorouracil
  • radiotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dermatitis herpetiformis?

A

Chronic, autoimmune, blistering skin disease characterized by intensely itchy papules and vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Association with dermatitis herpetiformis?

A

Coeliac disease // gluten sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical features of dermatitis herpetiformis?

A
  • Symmetrical, erythematous, and intensely pruritic papules and vesicles
  • Distributed over extensor surfaces - elbows, knees, and buttocks
  • Lesions may also appear on scalp, face, and neck
  • Scratching often leads to excoriation and crusting
  • Periods of exacerbation and remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Investigations for dermatitis herpetiformis?

A
  • Skin biopsy on perilesional skin for direct immunofluorescence (DIF) microscopy - granular IgA deposits in the dermal papillae
  • Histopathology of lesional skin - subepidermal blisters with neutrophilic infiltration in the dermal papillae
  • Serologic testing - IgA anti-tTG antibodies (also found in coeliac disease)
  • Screening for coeliac disease is recommended
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of dermatitis herpetiformis?

A
  • Strict, lifelong gluten-free diet - reduction in IgA anti-tTG antibodies, resolution of skin lesions, and prevention of potential complications associated with untreated coeliac disease
  • Dapsone - sulfone abx to provide relief of severe pruritus and skin lesions
  • Other medications, such as sulfapyridine and colchicine, can be considered in patients who cannot tolerate dapsone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Eczema herpeticum?

A

Potentially serious primary infection of the skin by herpes simplex virus 1 or 2, which typically affects people with atopic dermatitis or eczema but may also affect those with other inflammatory skin conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical features of eczema herpeticum?

A

> > Rapidly progressing painful rash

  • Areas of rapidly worsening, painful eczema
  • Vesicular rash
  • Blisters may be filled with clear yellow fluid, thick purulent material or blood stained
  • Punched-out erosions (circular, depressed, ulcerated lesions) usually 1-3mm that are uniform in appearance (monomorphic)
  • Initially form over areas affected by atopic dermatitis but spreads to involve normal skin over 1-2 weeks
  • These may coalesce to form larger areas of erosion with crusting
  • Typically the lesions will heal over 2-6 weeks
  • Possible fever, lethargy, lymphadenopathy or distress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Investigations for eczema herpeticum?

A

In any cases where eczema herpeticum is suspected:

  • Referral to a specialist paediatric dermatologist
  • Eczema herpeticum involving the skin around the eyes should be referred for same-day ophthalmology review

Viral infection can be confirmed by viral swabs sent for:

  • PCR, viral culture, direct fluorescent antibody stain

If herpetic keratitis is suspected:

  • Staining with fluorescein
  • A stained dendritic ulcer is diagnostic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Management of eczema herpeticum?

A

> > Dermatological emergency

Prompt treatment with antiviral medication should eliminate the need for hospital admission:

  • (1) Oral aciclovir 5 times daily for 10-14 days
  • Alternative: valaciclovir twice daily for 10-14 days
  • (2) children / if patient vomiting / unable to take tablets: IV aciclovir

Management of ocular involvement involves:

  • Ganciclovir ointment five times daily (3 hourly) for 7-10 days
  • Alternatives: trifluridine drops 1 drop nine times daily for 7-10 days followed by dose tapering
  • A corneal transplant may be indicated in cases of postherpetic scarring that significantly affects vision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Complications of eczema herpeticum?

A

Secondary infection (most common):

  • Staph aureus might cause impetigo
  • Strep may cause cellulitis

Herpetic keratitis:

  • Infection of the cornea
  • If untreated, can lead to blindness

Organ failure and dissemination:

  • Particularly, the brain, lungs and liver
  • May result in septic shock, meningitis, encephalitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Impetigo?

A

Superficial bacterial skin infection usually caused by either Staphylcoccus aureus or Streptococcus pyogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clinical features of impetigo?

A
  • Lesions tend to occur on the face, flexures and limbs not covered by clothing
  • ‘Golden’, crusted skin lesions
  • Very contagious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Management of impetigo?

A

Limited, localised disease:

  • Hydrogen peroxide 1% cream for ‘people who are not systemically unwell or at a high risk of complications’
  • Topical antibiotic creams - fusidic acid (mupirocin if fusidic acid resistance suspected / MRSA)

Extensive disease:

  • Oral flucloxacillin
  • Oral erythromycin if penicillin-allergic

School exclusion:

  • Children should be excluded from school until the lesions are crusted and healed or 48 hours after commencing antibiotic treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Intertrigo?

A

Dermatitis that affects a skin fold, for example underneath a breast. It may be non-infective but is commonly complicated by a secondary fungal infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Clinical features of intertrigo?

A
  • Erythematous rash on a skin fold
  • Skin may become moist and macerated
  • Typical sites include underneath the breast fold, in the groin, axilla, between the buttocks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Management of intertrigo?

A
  • General measures - zinc oxide ointment
  • Fungal infection - clotrimazole, miconazole
  • Erythrasma infection - erythromycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Keratoacanthoma?

A

Rapidly growing, self-resolving, low-grade cutaneous tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Clinical features of keratoacantoma?

A
  • Rrapidly-growing, dome-shaped cutaneous lesion with a central keratin plug
  • Usually solitary
  • Evolves over weeks to months, eventually stabilising and sometimes regressing spontaneously
  • Hallmark = rapid growth, followed by a plateau phase, and potentially a resolution phase.
  • Most commonly found on sun-exposed areas - face, neck, and extremities (may also occur on mucous membranes)
  • Sometimes local trauma or scarring is implicated in the lesion’s onset
  • Symmetry generally well maintained - ie benign appearance
  • Nodule or papule often flesh-coloured to erythematous, surrounded by a wall of inflamed tissue, with a central, keratin-filled crater
  • Surface of lesion often smooth, although crust or scale may be present
  • May be tender or painful depending on size and location
  • Some KAs may present with a superficial ulcerated surface.
  • Multiple lesions may be present in syndromic forms such as Ferguson-Smith syndrome or Muir-Torre syndrome.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Management of keratoacanthoma?

A
  • Spontaneous regression within 3 months common, often resulting in a scar
  • Such lesions should however be urgently excised as it is difficult clinically to exclude SCC
  • Removal also may prevent scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Clinical features of molluscum contagiosum?

A
  • Characteristic pinkish or pearly white papules with a central umbilication, which are up to 5 mm in diameter
  • Lesions appear in clusters in areas anywhere on the body (except the palms of the hands and the soles of the feet)
  • Children - commonly seen on trunk and in flexures, but anogenital lesions may also occur
  • Adults - sexual contact may lead to lesions developing on the genitalia, pubis, thighs, and lower abdomen
  • Rarely, lesions can occur on the oral mucosa and on the eyelids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Management molluscum contagiosum?

A

Self-care advice:

  • Self-limiting condition // spontaneous resolution usually occurs <18 months
  • Avoid sharing towels, clothing, and baths with uninfected people
  • Avoid scratching lesions - if problematic, consider treatment to alleviate the itch

If lesions are troublesome or considered unsightly, use simple trauma or cryotherapy:

  • Squeezing (with fingernails) or piercing (orange stick) lesions may be tried, following a bath (limited to a few lesions at one time)
  • Cryotherapy may be used in older children or adults

Treatment may be required if:

  • Itching is problematic - prescribe an emollient and mild topical corticosteroid (e.g. hydrocortisone 1%)
  • Skin looks infected (e.g. oedema, crusting) - prescribe a topical antibiotic (e.g. fusidic acid 2%)

Referral may be necessary in some circumstances:

  • HIV-positive + extensive lesions = urgent referral to a HIV specialist
  • Eyelid-margin or ocular lesions + associated red eye = urgent referral to an ophthalmologist
  • Adults with anogenital lesions = referral to genito-urinary medicine, for screening for other STIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Periorificial dermatitis?

A

Inflammatory disorder of the skin which is characterised by the eruption of multiple erythematous papules and pustules around the eyes, nose and mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Clinical features of periorificial dermatitis?

A

> > Most commonly seen in young females

Classical type:

  • Clusters of follicular papules and pustules overlying an erythematous base, with or without scaling
  • The inflammation is limited only to the skin surrounding the mouth, nose and eyes.
  • Around the mouth, the skin of the vermilion border is often spared, this is characteristic of cPOD
  • Burning or stinging in the area of the lesions. Itching is rare, but can occur.
  • Patients may have noticed rash after using a new medication (e.g. corticosteroids), skincare or cosmetic product

Granulomatous type:

  • Rarer variant - typically occurs in prepubescent children, most common of Afro-Caribbean ethnicity
  • Flesh coloured or yellow-brown coloured papules or plaques around the mouth, nose and lower eyelids
  • Erythema and scaling is less prominent, helping to differentiate this from classical POD
  • Biopsy of these lesions will reveal perifollicular granulomatous infiltration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Management of periorificial dermatitis?

A

> > Benign and self-limiting (many patients reach symptom resolution without intervention)
If symptoms are troublesome / persistent, pharmacological therapy should be initiated

Zero therapy:

  • Discontinuing the use of all topical facial products which may have triggered or could have exacerbated POD symptoms:
  • Discontinue the use of corticosteroids on the face and encourage patients using them elsewhere on the body to wash their hands thoroughly after application to prevent transfer to the face
  • Avoidance of topical skincare/cosmetic products which may irritate the skin
  • Once POD has resolved patients can restart topical products slowly and individually to allow the skin to respond to each product and allow the discontinuation of any known POD triggering product

Pharmacological therapies:
Mild POD (lesions covering only a small area):

  • Initial therapy: Topical antibiotic cream, such as erythromycin or metronidazole
  • Second line therapy: Topical tacrolimus ointment or pimecrolimus cream

Moderate or severe POD (lesions covering large areas of the face) or whose symptoms have not resolved with topical therapy:

  • Initial therapy: oral antibiotic therapy, typically with tetracycline, is recommended. This is typically used for 4-8 weeks
  • Erythromycin can be substituted for one of the tetracycline’s if they are not well tolerated or contraindicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Clinical features of pityriasis rosea?

A
  • Usually no prodrome, but minority recent viral infection
  • Acute onset of a solitary, oval-shaped herald patch (usually on trunk)
  • Followed by smaller, erythematous, oval, scaly patches in a characteristic ‘Christmas tree’ distribution along the Langer’s lines
  • Pruritus may be present and can range from mild to severe in intensity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Management of pityriasis rosea?

A

> > Self-limiting (not contagious and recurrences are rare)

Symptomatic relief:

  • Topical corticosteroids - mild-to-moderate potency (e.g., hydrocortisone or clobetasone butyrate) for short-term use (<2 weeks)
  • Emollients - regular application
  • Oral antihistamines - cetirizine or loratadine

Ultraviolet (UV) therapy:

  • In severe or persistent cases
  • Narrowband UVB phototherapy may be considered as an adjunct treatment
  • Expedites resolution of the rash and provides symptomatic relief
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Pityriasis versicolor?

A

Superficial cutaneous fungal infection caused by Malassezia furfur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Clinical features of pityriasis versicolor?

A
  • Most commonly affects trunk
  • Patches may be hypopigmented, pink or brown (hence versicolor). May be more noticeable following a suntan
  • Scale is common
  • Mild pruritus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Management of pityriasis versicolor?

A
  • Topical antifungal - ketoconazole shampoo
  • If failure to respond to topical treatment then consider alternative diagnoses (e.g. send scrapings to confirm the diagnosis) + oral itraconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Clinical features of pyoderma gangrenosum?

A
  • Usually starts quite suddenly
  • Typically on the lower limb
  • Soften at the site of a minor injury (pathergy)
  • Small pustule, red bump or blood-blister
  • Skin then breaks down resulting in an ulcer which is often painful
  • Edge of the ulcer is often described as purple, violaceous and undermined
  • Ulcer itself may be deep and necrotic
  • May be accompanied by systemic symptoms - fever, myalgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Management of pyoderma gangrenosum?

A

> > Potential for rapid progression is high in most patients

  • First line = oral steroids
  • Other immunosuppressive therapy, e.g., ciclosporin and infliximab, in difficult cases
  • Any surgery should be postponed until the disease process is controlled on immunosuppression to risk worsening of the disease (pathergy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Pyogenic granuloma?

A

Benign vascular proliferation that commonly manifests as a rapidly growing, friable, erythematous papule or nodule, frequently observed on the skin and mucous membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Clinical features of pyogenic granuloma?

A
  • Most common sites are head/neck, upper trunk and hands
  • Lesions in the oral mucosa are common in pregnancy
  • Initially small red/brown spot
  • Rapidly progress within days to weeks forming raised, red/brown lesions which are often spherical in shape
  • Lesions may bleed profusely or ulcerate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Management of pyogenic granuloma?

A
  • Lesions associated with pregnancy often resolve spontaneously post-partum
  • Other lesions usually persist
  • Removal methods include curettage and cauterisation, cryotherapy, excision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Rosacea?

A

Chronic, inflammatory skin condition that primarily affects the face, causing redness, flushing, and visible blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Classification of rosacea?

A
  • Erythematotelangiectatic rosacea (ETR): Characterized by facial redness, flushing, and visible blood vessels (telangiectasias).
  • Papulopustular rosacea: Presents with acne-like breakouts, including papules and pustules, along with facial redness and swelling.
  • Phymatous rosacea: Associated with skin thickening, especially around the nose (rhinophyma), and can also affect the chin, forehead, cheeks, and ears.
  • Ocular rosacea: Involves the eyes, causing redness, burning, itching, and the sensation of a foreign body. It can lead to complications such as blepharitis, conjunctivitis, and keratitis if not treated promptly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Clinical features of rosacea?

A
  • Typically affects nose, cheeks and forehead
  • Flushing is often first symptom
  • Telangiectasia are common
  • Later develops into persistent erythema with papules and pustules
  • Rhinophyma
  • Ocular involvement: blepharitis
  • Sunlight may exacerbate symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Management of rosacea?

A
  • Daily application of a high-factor sunscreen
  • Predominant erythema/flushing but limited telangiectasia - topical brimonidine gel (used on an ‘as required basis’ to temporarily reduce redness)
  • Mild-to-moderate papules and/or pustules - topical ivermectin
  • Alternatives include: topical metronidazole or topical azelaic acid
  • Moderate-to-severe papules and/or pustules - combination of topical ivermectin + oral doxycycline

Referral should be considered if:

  • Symptoms have not improved with optimal management in primary care
  • Laser therapy may be appropriate for patients with prominent telangiectasia
  • Patients with a rhinophyma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Sacbies?

A

Caused by the mite Sarcoptes scabiei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Clinical features of scabies?

A
  • widespread pruritus
  • linear burrows on the side of fingers, interdigital webs and flexor aspects of the wrist - ‘silver lines’
  • in infants, the face and scalp may also be affected
  • secondary features are seen due to scratching: excoriation, infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Management of scabies?

A
  • permethrin 5% is first-line
  • 2 applications, 1 week apart
  • malathion 0.5% is second-line

Guidance:

  • avoid close physical contact with others until treatment is complete
  • all household and close physical contacts should be treated at the same time, even if asymptomatic
  • launder, iron or tumble dry clothing, bedding, towels, etc., on the first day of treatment to kill off mites.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Clinical features of seborrhoeic dermatitis in adults?

A
  • Eczematous lesions on the sebum-rich areas - scalp (may cause dandruff), periorbital, auricular and nasolabial folds
  • Otitis externa and blepharitis may develop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Management of seborrhoeic dermatitis in adults?

A

Scalp disease management:

  • First-line = ketoconazole 2% shampoo
  • OTC preparations containing zinc pyrithione (‘Head & Shoulders’) and tar (‘Neutrogena T/Gel’) if ketoconazole not appropriate or acceptable to the person
  • Selenium sulphide and topical corticosteroid may also be useful

Face and body management:

  • topical antifungals: e.g. ketoconazole
  • topical steroids: best used for short periods
  • difficult to treat - recurrences are common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Clinical features of seborrhoeic dermatitis in children?

A
  • Erythematous patches with greasy scales predominantly on sebum-rich areas
  • Typically affects the scalp (‘Cradle cap’), nappy area, face and limb flexures.
  • Cradle cap is an early sign which may develop in the first few weeks of life - characterised by an erythematous rash with coarse yellow scales
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Management of seborrhoeic dermatitis in children?

A
  • Reassurance that it doesn’t affect the baby and usually resolves within a few weeks
  • Massage a topical emollient onto the scalp to loosen scales, brush gently with a soft brush and wash off with shampoo.
  • If severe/persistent a topical imidazole cream may be tried
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Clinical features of Shingles?

A

Prodrome:

  • Acute neuralgia - tingling, burning, itching or occasionally stabbing in nature
  • Non-specific symptoms such as malaise, fatigue, headache
  • Enlarged lymph nodes in region of affected area
  • Typically 2-3 days long, may last up to a week

Infectious phase:

  • Rash usually affecting a single dermatome in a band-like distribution
  • Unilateral, rarely crossing the midline
  • Initially is erythematous and macular in nature
  • Progression to erythematous papules, and eventually vesicles or bullae by day 7
  • Vesicles become pustular or haemorrhagic near the end of this phase, right before crusting over
  • Pain located around the region where the rash is located
  • Very rarely, the rash is painless (typically this occurs in children)
  • Lasts approximately 7-10 days

Resolution phase:

  • The vesicular rash crusts over within 10-12 days of rash onset
  • The crusted lesions can take up to one month to completely disappear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Management of shingles?

A

Supportive management:

  • Common mild analgesics, such as paracetamol alone or in combination with codeine or NSAIDs such as ibuprofen
  • In cases of moderate-severe pain, add either amitriptyline, duloxetine, gabapentin or pregabalin
  • Calamine lotion application to affected skin can provide relief to both pain and pruritis, if present
  • Topical capsaicin can be considered and can provide some pain relief
  • Cool compresses on affected area a few times a day

Anti-viral therapy:
Oral antiviral within 72 hours of rash onset if:

  • Immunocompromised patients
  • Non-truncal rash involvement (e.g. affecting face, neck, limbs, perineum)
  • Moderate-severe pain or rash
  • Consider prescribing anti-viral therapy if aged >50-years-old (to reduce incidence of post-herpetic neuralgia)

Oral aciclovir, famciclovir, or valaciclovir

  • Can still be considered up to one week after onset of the rash
  • IV considered, only if oral therapy is not tolerated

Corticosteroids:

  • If a patient is on anti-viral treatment, consider course of oral corticosteroids
  • Used in the first 2 weeks following the onset of the rash
  • This should only be used in conjunction with anti-viral treatment, and in immunocompetent adults with localised shingles if the pain is severe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Post-herpetic neuralgia?

A
  • Most common complication of shingles
  • Persistent pain in region of rash, even after rash and acute illness is resolved (lasting >1 month)
  • Burning, shooting or tingling pain
  • Hyperalgesia or allodynia over region affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Management of post-herpetic neuralgia?

A
  • Begin with mild analgesics (NSAIDs +/- paracetamol)
  • Opioid analgesics can be added if mild pain relief is not sufficient
  • As the pain is neuropathic in nature, it may respond to a tricyclic anti-depressant or anti-convulsant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

RFs for SCC?

A
  • excessive exposure to sunlight / psoralen UVA therapy
  • actinic keratoses and Bowen’s disease
  • immunosuppression e.g. following renal transplant, HIV
  • smoking
  • long-standing leg ulcers (Marjolin’s ulcer)
  • genetic conditions e.g. xeroderma pigmentosum, oculocutaneous albinism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Clinical features of SCC?

A
  • Rough, reddish scaly area.
  • Open sore (often with a raised border)
  • Brown spot that looks like an age spot.
  • Firm, dome-shaped growth.
  • Wart-like growth.
  • Tiny, rhinoceros-shaped horn growing from your skin.
  • Sore developing in an old scar.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Management of SCC?

A
  • Surgical excision with 4mm margins if lesion <20mm in diameter
  • If tumour >20mm then margins should be 6mm
  • Mohs micrographic surgery may be used in high-risk patients and in cosmetically important sites
64
Q

Clinical features of toxic shock syndrome?

A
  • fever: temperature > 38.9ºC
  • hypotension: systolic blood pressure < 90 mmHg
  • diffuse erythematous rash
  • desquamation of rash, especially of the palms and soles
  • involvement of three or more organ systems: e.g. GI (diarrhoea and vomiting), mucous membrane erythema, renal failure, hepatitis, thrombocytopenia, CNS involvement (e.g. confusion)
65
Q

Tinea corporis?

A

Superficial fungal infection of the skin, often referred to as ringworm, due to the characteristic circular, ring-like rash it produces

66
Q

Clinical features of tinea corporis?

A
  • Erythematous, scaly plaques with an active, advancing, and often pruritic border
  • The centre of the lesion may clear up as it expands, resulting in a characteristic ring-like appearance, hence the name ringworm
  • The size, shape, and number of lesions can vary significantly between individuals.
67
Q

Diagnosis of tinea corporis?

A

If diagnostic uncertainty:

Potassium hydroxide (KOH) preparation of skin scrapings can be used to confirm the presence of fungal elements under microscopy

68
Q

Management of tinea corporis?

A
  • Topical antifungal medication such as clotrimazole or terbinafine for uncomplicated cases (at least 2 weeks)
  • In extensive, severe, or refractory cases, systemic antifungal therapy with agents such as terbinafine, itraconazole, or fluconazole may be necessary
69
Q

Clinical features of venous ulcers?

A
  • Typically occur in the gaiter area of the leg (from the ankle to the mid-calf), above the medial malleolus
  • They present as irregular, shallow wounds with a granulating base and are often accompanied by substantial exudate
  • The surrounding skin may show signs of chronic venous insufficiency, including oedema, pigmentation, lipodermatosclerosis (hardening and discolouration of the skin), and atrophie blanche (small, white scars surrounded by dilated capillaries)
  • Can be painful, but the degree of pain is usually less severe than that associated with arterial ulcers
70
Q

Investigations for venous ulcers?

A

Ankle-brachial pressure index:

  • Important in non-healing ulcers to assess for poor arterial flow which could impair healing
  • A ‘normal’ ABPI is between 0.9 - 1.2
  • Values below 0.9 indicate arterial disease
  • Values above 1.3 may also indicate arterial disease, in the form of false-negative results secondary to arterial calcification (e.g. In diabetics)

Doppler ultrasound examination:

  • Often used to assess the venous system’s competence and exclude arterial disease, particularly if the patient is to be considered for compression therapy.

> > If the ulcer does not respond to standard treatment, or if malignancy is suspected, a biopsy may be performed.

71
Q

Management of venous ulcers?

A
  • Compression therapy (improves venous return and reduces oedema) - multilayer bandages or compression stockings.
  • Wound care - regular cleaning and dressing
  • Topical agents may be used to control bacterial overgrowth and promote wound healing. In some cases, debridement may be required.
  • Systemic treatment can include analgesics for pain control and, if indicated, antibiotics for cellulitis
  • In patients with recurrent or non-healing ulcers, surgical interventions such as endovenous ablation, sclerotherapy, or venous valve repair may be considered.
72
Q

Alopecia areata?

A

Presumed autoimmune condition causing localised, well demarcated patches of hair loss. At the edge of the hair loss, there may be small, broken ‘exclamation mark’ hairs

73
Q

Management of alopecia areata?

A

Hair will regrow in 50% of patients by 1 year, and in 80-90% eventually. Careful explanation is therefore sufficient in many patients.

Other treatment options include:

  • topical or intralesional corticosteroids
  • topical minoxidil
  • phototherapy
  • dithranol
  • contact immunotherapy
  • wigs
74
Q

Clinical features of athletes food / tinea pedis?

A

Typically scaling, flaking, and itching between the toes

75
Q

Management of athletes foot?

A

topical imidazole, undecenoate, or terbinafine first-line

76
Q

Bowen’s Disease?

A

A type of precancerous dermatosis that is a precursor to squamous cell carcinoma

77
Q

Clinical features of Bowen’s Disease?

A
  • red, scaly patches - often 10-15 mm in size
  • slow-growing
  • often occur on sun-exposed areas such as the head (e.g. temples) and neck, lower limbs
78
Q

Management of Bowen’s Disease?

A
  • topical 5-fluorouracil
  • typically used twice daily for 4 weeks
  • often results in significant inflammation/erythema. Topical steroids are often given to control this
  • cryotherapy
  • excision
79
Q

Bullous pemphigoid?

A

Autoimmune condition causing sub-epidermal blistering of the skin.

This is secondary to the development of antibodies against hemidesmosomal proteins BP180 and BP230

80
Q

Clinical features of bullous pemphigoid?

A
  • more common in the elderly
  • itchy, tense blisters typically around flexures
  • the blisters usually heal without scarring
  • there is stereotypically no mucosal involvement (i.e. the mouth is spared)
81
Q

Skin biopsy findings in bullous pemphigoid?

A

immunofluorescence shows IgG and C3 at the dermoepidermal junction

82
Q

Management of bullous pemphigoid?

A
  • Referral to a dermatologist for biopsy and confirmation of diagnosis
  • Oral corticosteroids are the mainstay of treatment
  • Topical corticosteroids, immunosuppressants and antibiotics are also used
83
Q

Auspitz’s sign?

A

In psoriasis, if the scale is removed, a red membrane with pinpoint bleeding points may be seen

84
Q

Types of contact dermatitis?

A
  • Irritant contact dermatitis: common - non-allergic reaction due to weak acids or alkalis (e.g. detergents). Often seen on the hands. Erythema is typical, crusting and vesicles are rare
  • Allergic contact dermatitis: type IV hypersensitivity reaction. Uncommon - often seen on the head following hair dyes. Presents as an acute weeping eczema which predominately affects the margins of the hairline rather than the hairy scalp itself. Topical treatment with a potent steroid is indicated
85
Q

Frequent cause of contact dermatitis?

A

Cement

Both irritant contact dermatitis and allergic contact dermatitis

86
Q

Dermatofibroma?

A

// Histiocytomas

Common benign fibrous skin lesions. They are caused by the abnormal growth of dermal dendritic histiocyte cells, often following a precipitating injury

87
Q

Clinical features of dermatofibromas?

A
  • solitary firm papule or nodule, typically on a limb
  • typically around 5-10mm in size
  • overlying skin dimples on pinching the lesion
88
Q

Describe topical steroids by potency

A
89
Q

Erysipelas?

A

Localised skin infection caused by Streptococcus pyogenes. In simple terms, it is a more superficial, limited version of cellulitis.

The treatment of choice is flucloxacillin.

90
Q

Erythema ab igne?

A

Skin disorder caused by over exposure to infrared radiation.

Characteristic features include reticulated, erythematous patches with hyperpigmentation and telangiectasia.

A typical history would be an elderly women who always sits next to an open fire.

If the cause is not treated then patients may go on to develop squamous cell skin cancer.

91
Q

Erythema multiforme?

A

Hypersensitivity reaction that is most commonly triggered by infections

92
Q

Clinical features of erythema multiforme?

A
  • target lesions
  • initially seen on the back of the hands / feet before spreading to the torso
  • upper limbs are more commonly affected than the lower limbs
  • pruritus is occasionally seen and is usually mild
93
Q

Causes of erythema multiforme?

A
  • viruses: HSV (most common cause), Orf
  • idiopathic
  • bacteria: Mycoplasma, Streptococcus
  • drugs: penicillin, sulphonamides, carbamazepine, allopurinol, NSAIDs, oral contraceptive pill, nevirapine
  • connective tissue disease e.g. SLE
  • sarcoidosis
  • malignancy
94
Q

Erythema multiforme major?

A

The more severe form, erythema multiforme major is associated with mucosal involvement.

95
Q

Clinical features of Erythrasma?

A

asymptomatic, flat, slightly scaly, pink or brown rash usually found in the groin or axillae

96
Q

Investigations for erythrasma?

A

Examination with Wood’s light reveals a coral-red fluorescence

97
Q

Management of erythrasma?

A

Topical miconazole or antibacterial are usually effective.
Oral erythromycin may be used for more extensive infection

98
Q

Erythroderma?

A

Term used when more than 95% of the skin is involved in a rash of any kind.

99
Q

Causes of erythroderma?

A
  • eczema
  • psoriasis
  • drugs e.g. gold
  • lymphomas, leukaemias
  • idiopathic
100
Q

Erythrodermic psoriasis?

A
  • May result from progression of chronic disease to an exfoliative phase with plaques covering most of the body
  • Associated with mild systemic upset
  • More serious form is an acute deterioration.
  • This may be triggered by a variety of factors such as withdrawal of systemic steroids.
  • Patients need to be admitted to hospital for management
101
Q

Clinical features of fungal nail infection?

A
  • ‘unsightly’ nails are a common reason for presentation
  • thickened, rough, opaque nails are the most common finding
102
Q

Investigations for fungal nail infection?

A

Nail clippings +/- scrapings of the affected nail:

  • microscopy and culture
  • should be done for all patients if antifungal treatment is being considered
  • the false-negative rate for cultures are around 30%, so repeat samples may need to be sent if the clinical suspicion is high
103
Q

Management of fungal nail infections?

A

> > Do not need to be treated if it is asymptomatic and the patient is not bothered by the appearance

Dermatophyte or Candida infection confirmed:

  • Limited involvement (≤50% nail affected, ≤ 2 nails affected, more superficial white onychomycosis): topical treatment with amorolfine 5% nail lacquer; 6 months for fingernails and 9 - 12 months for toenails
  • More extensive involvement due to a dermatophyte infection: oral terbinafine first-line; 6 weeks - 3 months therapy is needed for fingernail infections whilst toenails should be treated for 3 - 6 months
  • More extensive involvement due to a Candida infection: oral itraconazole first-line; ‘pulsed’ weekly therapy is recommended
104
Q

Clinical features of hidradenitis suppurativa?

A
  • Initial manifestation involves recurrent, painful, and inflamed nodules.
  • Most commonly on intertriginous skin
  • Axilla is the most common site
  • Other areas include inguinal, inner thighs, perineal and perianal, inframammary skin.
  • The nodules may rupture, discharging purulent, malodorous material.
  • Coalescence of nodules can result in plaques, sinus tracts and ‘rope-like’ scarring.
105
Q

Management of hidradenitis suppurativa?

A
  • Encourage good hygiene and loose-fitting clothing
  • Smoking cessation
  • Weight loss in obese
  • Acute flares can be treated with steroids (intra-lesional or oral) or flucloxacillin. Surgical incision and drainage may be needed in some cases.
  • Long-term disease can be treated with topical (clindamycin) or oral (lymecycline or clindamycin and rifampicin) antibiotics.
  • Lumps that persist despite prolonged medical treatment are excised surgically.
106
Q

Management of hyperhidrosis?

A
  • topical aluminium chloride preparations are first-line. Main side effect is skin irritation
  • iontophoresis: particularly useful for patients with palmar, plantar and axillary hyperhidrosis
  • botulinum toxin: currently licensed for axillary symptoms
  • surgery: e.g. Endoscopic transthoracic sympathectomy. Patients should be made aware of the risk of compensatory sweating
107
Q

Clinical features of lichen planus?

A
  • itchy, papular rash most common on the palms, soles, genitalia and flexor surfaces of arms
  • rash often polygonal in shape, with a ‘white-lines’ pattern on the surface (Wickham’s striae)
  • Koebner phenomenon may be seen (new skin lesions appearing at the site of trauma)
  • oral involvement in around 50% of patients: typically a white-lace pattern on the buccal mucosa
  • nails: thinning of nail plate, longitudinal ridging
108
Q

Management of lichen planus?

A
  • potent topical steroids are the mainstay of treatment
  • benzydamine mouthwash or spray is recommended for oral lichen planus
  • extensive lichen planus may require oral steroids or immunosuppression
109
Q

Clinical features of lichen sclerosus?

A
  • usually affects the genitalia
  • more common in elderly females
  • white patches / plaques that may scar
  • itch is prominent
  • may result in pain during intercourse or urination
110
Q

Management of lichen sclerosus?

A

topical steroids and emollients

Follow-up - increased risk of vulval cancer

111
Q

Types of malignant melanoma?

A
112
Q

Diagnostic criteria for malignant melanoma?

A

Major criteria:

  • Change in size
  • Change in shape
  • Change in colour

Secondary features (minor criteria):

  • Diameter >= 7mm
  • Inflammation
  • Oozing or bleeding
  • Altered sensation
113
Q

Management of malignant melanoma?

A
  • Suspicious lesions should undergo excision biopsy. - The lesion should be removed completely as incision biopsy can make subsequent histopathological assessment difficult.
  • Once the diagnosis is confirmed the pathology report should be reviewed to determine whether further re-excision of margins is required

Further treatments such as sentinel lymph node mapping, isolated limb perfusion and block dissection of regional lymph node groups should be selectively applied.

114
Q

Most important factor in determining prognosis of patients with malignant melanoma?

A

The invasion depth of a tumour (Breslow depth)

115
Q

Mycosis fungoides?

A

Rare form of T-cell lymphoma that affects the skin

  • itchy, red patches which are
  • lesions tend to be of different colours in contrast to eczema/psoriasis where there is greater homogenicity
116
Q

Pellagra?

A

3 D’s - dermatitis, diarrhoea and dementia

may occur as a consequence of isoniazid therapy (isoniazid inhibits the conversion of tryptophan to niacin) and it is more common in alcoholics.

117
Q

Pemphigus vulgaris?

A

Autoimmune disease caused by antibodies directed against desmoglein 3

118
Q

Clinical features of pemphigus vulgaris?

A
  • mucosal ulceration is common and often the presenting symptom
  • skin blistering - flaccid, easily ruptured vesicles and bullae
  • Lesions are typically painful but not itchy. These may develop months after the initial mucosal symptoms.
  • Nikolsky’s describes the spread of bullae following application of horizontal, tangential pressure to the skin
  • acantholysis on biopsy
119
Q

Management of pemphigus vulgaris?

A

steroids are first-line
immunosuppressants

120
Q

Pompholyx?

A

Type of eczema which affects both the hands (cheiropompholyx) and the feet (pedopompholyx). It is also known as dyshidrotic eczema.

121
Q

Clinical features of pompholyx?

A
  • may be precipitated by humidity (e.g. sweating) and high temperatures
  • small blisters on the palms and soles
  • pruritic
  • often intensely itchy
  • sometimes burning sensation
  • once blisters burst skin may become dry and crack
122
Q

Management of pompholyx?

A

cool compresses
emollients
topical steroids

123
Q

Porphyria cutanea tarda?

A

most common hepatic porphyria. It is due to an inherited defect in uroporphyrinogen decarboxylase or caused by hepatocyte damage e.g. alcohol, hepatitis C, oestrogen

124
Q

Clinical features of PCT?

A
  • classically presents with photosensitive rash with blistering and skin fragility on the face and dorsal aspect of hands (most common feature)
  • hypertrichosis
  • hyperpigmentation
125
Q

Investigations for PCT?

A
  • urine: elevated uroporphyrinogen and pink fluorescence of urine under Wood’s lamp
  • serum iron ferritin level is used to guide therapy
126
Q

Management of PCT?

A

chloroquine
venesection - preferred if iron ferritin is above 600 ng/ml

127
Q

Nail features of psoriasis?

A
  • pitting
  • onycholysis
  • subungual hyperkeratosis
  • loss of the nail
  • associated with psoriatic arthropathy
128
Q

Factors which exacerbate psoriasis?

A
  • trauma
  • alcohol
  • drugs: beta blockers, lithium, antimalarials (chloroquine and hydroxychloroquine), NSAIDs and ACE inhibitors, infliximab
  • withdrawal of systemic steroids
  • Streptococcal infection may trigger guttate psoriasis.
129
Q

Management of chronic plaque psoriasis?

A
  • regular emollients may help to reduce scale loss and reduce pruritus
  • first-line = potent corticosteroid applied once daily plus vitamin D analogue applied once daily
  • should be applied separately, one in the morning and the other in the evening)
  • for up to 4 weeks as initial treatment
  • second-line (no improvement after 8 weeks) = vitamin D analogue twice daily
  • third-line (no improvement after 8-12 weeks) = potent corticosteroid applied twice daily for up to 4 weeks, or
    a coal tar preparation applied once or twice daily
  • short-acting dithranol can also be used
130
Q

Secondary care management of psoriasis?

A

Phototherapy:

  • narrowband ultraviolet B light is now the treatment of choice
  • 3 times a week
  • photochemotherapy is also used - psoralen + ultraviolet A light (PUVA)
  • adverse effects: skin ageing, squamous cell cancer (not melanoma)

Systemic therapy:

  • oral methotrexate first-line
  • particularly useful if associated joint disease
  • ciclosporin
  • systemic retinoids
  • biological agents: infliximab, etanercept and adalimumab
    ustekinumab (IL-12 and IL-23 blocker) is showing promise in early trials
131
Q

Management of scalp psoriasis?

A
  • first line = potent topical corticosteroids used once daily for 4 weeks
  • second line (no improvement after 4 weeks) = either use a different formulation of the potent corticosteroid (for example, a shampoo or mousse) and/or a topical agents to remove adherent scale (for example, agents containing salicylic acid, emollients and oils) before application of the potent corticosteroid
132
Q

Management of face / flexural / genital psoriasis?

A

mild or moderate potency corticosteroid applied once or twice daily for a maximum of 2 weeks

133
Q

Seborrhoeic keratoses?

A

Benign epidermal skin lesions seen in older people

  • large variation in colour from flesh to light-brown to black
  • have a ‘stuck-on’ appearance
  • keratotic plugs may be seen on the surface

> > reassurance about the benign nature of the lesion is an option
options for removal include curettage, cryosurgery and shave biopsy

134
Q

Skin conditions associated with SLE?

A

photosensitive ‘butterfly’ rash
discoid lupus
alopecia
livedo reticularis: net-like rash

135
Q

Stevens-Johnson Syndrome?

A

Severe systemic reaction affecting the skin and mucosa that is almost always caused by a drug reaction.

  • penicillin
  • sulphonamides
  • lamotrigine, carbamazepine, phenytoin
  • allopurinol
  • NSAIDs
  • oral contraceptive pill
136
Q

Clinical features of SJS?

A
  • rash is typically maculopapular with target lesions being characteristic
  • may develop into vesicles or bullae
  • Nikolsky sign is positive in erythematous areas - blisters and erosions appear when the skin is rubbed gently
  • mucosal involvement
  • systemic symptoms: fever, arthralgia
137
Q

Management of SJS?

A

hospital admission is required for supportive treatment

138
Q

Toxic epidermal necrolysis?

A

Potentially life-threatening skin disorder that is most commonly seen secondary to a drug reaction

  • phenytoin
  • sulphonamides
  • allopurinol
  • penicillins
  • carbamazepine
  • NSAIDs
139
Q

Clinical features of TEN?

A
  • skin develops a scalded appearance over an extensive area
  • systemically unwell e.g. pyrexia, tachycardic
  • positive Nikolsky’s sign: the epidermis separates with mild lateral pressure
140
Q

Management of TEN?

A
  • stop precipitating factor
  • supportive care, often in ICU
  • IV immunoglobulin first-line
  • other treatment options include: immunosuppressive agents (ciclosporin and cyclophosphamide), plasmapheresis
141
Q

Clinical features of vitiligo?

A
  • well-demarcated patches of depigmented skin
  • the peripheries tend to be most affected
  • trauma may precipitate new lesions (Koebner phenomenon)
142
Q

Management of vitiligo?

A
  • sunblock for affected areas of skin
  • camouflage make-up
  • topical corticosteroids may reverse the changes if applied early
  • there may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light-skinned patients
143
Q

Most common malignancy associated with acanthosis nigricans?

A

Gastrointestinal adenocarcinoma

144
Q

How is the extent of a burn assessed?

A
  • Wallace’s Rule of Nines: head + neck = 9%, each arm = 9%, each anterior part of leg = 9%, each posterior part of leg = 9%, anterior chest = 9%, posterior chest = 9%, anterior abdomen = 9%, posterior abdomen = 9%
  • Lund and Browder chart: most accurate method, the palmar surface is roughly equivalent to 1% of total body surface area (TBSA). Not accurate for burns > 15% TBSA
144
Q

Immediate first aid of burns?

A

Burns caused by heat:

  • Remove the person from the source
  • Within 20 minutes of the injury irrigate the burn with cool (not iced) water for between 10 and 30 minutes
  • Cover the burn using cling film, layered, rather than wrapped around a limb

Electrical burns:

  • switch off power supply, remove the person from the source

Chemical burns:

  • Brush any powder off then irrigate with water
  • Attempts to neutralise the chemical are not recommended
145
Q

How is the depth of a burn assessed?

A
146
Q

When should a burn be referred to secondary care?

A
  • all deep dermal and full-thickness burns.
  • superficial dermal burns of more than 3% TBSA in adults, or more than 2% TBSA in children
  • superficial dermal burns involving the face, hands, feet, perineum, genitalia, or any flexure, or circumferential burns of the limbs, torso, or neck
  • any inhalation injury
  • any electrical or chemical burn injury
  • suspicion of non-accidental injury
147
Q

Management of severe burns?

A

Immediate:

  • Airway assessed first - early intubation considered e.g. if deep burns to face or neck, blisters or oedema of oropharynx, stridor etc
  • IV fluids for children with burns >10% TBSA / adults >15% TBSA
  • Fluids calculated using the Parkland formula - volume of fluid = TSBA of burn % x weight (Kg) x4. Half of the fluid is administered in the first 8 hours.
  • Urinary catheter inserted
  • Analgesia given
  • Complex burns, burns involving the hand, perineum and face and burns >10% in adults and >5% in children should be transferred to a burns unit.

More definitive:

  • Conservative management appropriate for superficial burns and mixed superficial burns that will heal in 2 weeks.
  • More complex burns may require excision and skin grafting.

Escharotomies:

  • Indicated in circumferential full thickness burns to the torso or limbs.
  • Careful division of the encasing band of burn tissue will potentially improve ventilation (if the burn involves the torso), or relieve compartment syndrome and oedema (where a limb is involved)
148
Q

Curling’s ulcers?

A

Acute gastric ulcers that develop in response to severe physiological stress, such as burns.

Haematemesis, or vomiting blood, is a common presentation of these ulcers.

149
Q

What chronic condition is most associated with seborrhoeic dermatitis?

A

HIV

150
Q

Clinical features of tinea capitis?

A
  • a cause of scarring alopecia mainly seen in children
  • flaky skin, itch, and hair loss
  • if untreated a raised, pustular, spongy/boggy mass called a kerion may form
151
Q

Management of tinea capitis?

A

oral antifungals: terbinafine for Trichophyton tonsurans infections and griseofulvin for Microsporum infections.

Topical ketoconazole shampoo should be given for the first two weeks to reduce transmission

151
Q

Classification of necrotising fasciitis?

A
  • type 1 = caused by mixed anaerobes and aerobes (often occurs post-surgery in diabetics). This is the most common type
  • type 2 = caused by Streptococcus pyogenes
151
Q

Clinical features of necrotising fasciitis?

A
  • acute onset
  • pain, swelling, erythema at the affected site
  • presence of bullae, purple discolouration
  • most commonly affected site is the perineum
  • often presents as rapidly worsening cellulitis with pain out of keeping with physical features
  • extremely tender over infected tissue with hypoaesthesia to light touch
  • skin necrosis and crepitus/gas gangrene are late signs
  • fever and tachycardia may be absent or occur late in the presentation
152
Q

Management of necrotising fasciitis?

A

urgent surgical referral debridement
intravenous antibiotics

153
Q

Clinical features of dermatomyositis?

A